Caroline Heise, MD
Gynecology · Doylestown, PANPI 1467444596
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 33.2% of the total. Reporting peaked in 2023 at $281 and has fallen 89.7% since, to $29 in 2024. That places this record below the midpoint for gynecology clinicians in PA, where the typical reported total is $657.
Across 25 payments — averaging $22.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$191
- Astellas Pharma US Inc$83
- Aspira Women's Health Inc$67
- Avion Pharmaceuticals$47
- Organon$46
- Coopersurgical, Inc.$45
- plus $96 from 3 others
What the payments were for
- Food & beverage$574100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $191 |
| Astellas Pharma US Inc | 3 | $83 |
| Aspira Women's Health Inc | 1 | $67 |
| Avion Pharmaceuticals | 3 | $47 |
| Organon | 2 | $46 |
| Coopersurgical, Inc. | 2 | $45 |
| Therapeuticsmd, Inc. | 2 | $39 |
| Mayne Pharma Commercial LLC | 2 | $38 |
| Hologic Sales And Service, LLC | 1 | $19 |
How this compares
$574 in reported general payments places this provider in the 45th percentile of 98 gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EstringEstradiol | 33 | $16,827 |
| PremproEstrogen,con/M-Progest Acet | 17 | $6,139 |
| Estradiol | 79 | $5,842 |
| YuvafemEstradiol | 26 | $4,316 |
| ValacyclovirValacyclovir Hcl | 51 | $1,627 |
| Betamethasone Valerate | 112 | $1,519 |
| Raloxifene Hcl | 17 | $668 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 73 | $599 |
| Alendronate Sodium | 48 | $369 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $250 |
| Fluconazole | 16 | $105 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Doylestown
- Laurie GersteinDoylestown$604
- Jordan KlebanoffNewtown Square$187K
- Harry ReichShavertown$136K
- Gretchen MakaiYork$102K
- Karen TangBryn Mawr$96K
- Joseph TalvacchiaPhiladelphia$85K
- David ToubWyncote$41K
- David EvansCarlisle$30K
- Harold DavisScranton$22K
- Reneita RossPhiladelphia$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.